Targeting the cytotoxicity of topoisomerase II-directed epipodophyllotoxins to tumor cells in acidic environments.

[1]  H. Hansen,et al.  Different modes of anthracycline interaction with topoisomerase II. Separate structures critical for DNA-cleavage, and for overcoming topoisomerase II-related drug resistance. , 1993, Biochemical pharmacology.

[2]  P. Wilairat,et al.  Structure-activity relationships and modes of action of 9-anilinoacridines against chloroquine-resistant Plasmodium falciparum in vitro , 1993, Antimicrobial Agents and Chemotherapy.

[3]  I. Tannock,et al.  Studies with glycolysis-deficient cells suggest that production of lactic acid is not the only cause of tumor acidity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J. Alsner,et al.  Mode of action of topoisomerase II-targeting agents at a specific DNA sequence. Uncoupling the DNA binding, cleavage and religation events. , 1992, Journal of molecular biology.

[5]  A. Cerami,et al.  Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites , 1992, Nature.

[6]  H. Hansen,et al.  Antagonistic effect of aclarubicin on daunorubicin-induced cytotoxicity in human small cell lung cancer cells: relationship to DNA integrity and topoisomerase II. , 1991, Cancer research.

[7]  H. Hansen,et al.  Antagonistic effect of aclarubicin on the cytotoxicity of etoposide and 4'-(9-acridinylamino)methanesulfon-m-anisidide in human small cell lung cancer cell lines and on topoisomerase II-mediated DNA cleavage. , 1990, Cancer research.

[8]  W. Wilson,et al.  Chemoprotection by 9-aminoacridine derivatives against the cytotoxicity of topoisomerase II-directed drugs. , 1989, European journal of cancer & clinical oncology.

[9]  P. Okunieff,et al.  Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. , 1989, Cancer research.

[10]  F. Grosse,et al.  Purification and characterization of DNA topoisomerase II from calf thymus associated with polypeptides of 175 and 150 kDa. , 1986, European journal of biochemistry.

[11]  L. de Leij,et al.  Characterization of three new variant type cell lines derived from small cell carcinoma of the lung. , 1985, Cancer research.

[12]  G. Kupfer,et al.  Inhibition of epipodophyllotoxin cytotoxicity by interference with topoisomerase-mediated DNA cleavage. , 1985, Biochemical pharmacology.

[13]  H. Ginsburg,et al.  Susceptibility of human malaria parasites to chloroquine is pH dependent. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[14]  L. Allen.  Comparison of uptake and binding of two epipodophyllotoxin glucopyranosides, 4'-demethyl epipodophyllotoxin thenylidene-beta-D-glucoside and 4'-demethyl epipodophyllotoxin ethylidene-beta-D-glucoside, in the L1210 leukemia cell. , 1978, Cancer research.

[15]  K. Kohn.  Principles and practice of DNA filter elution. , 1991, Pharmacology & therapeutics.

[16]  L. Liu,et al.  DNA topoisomerase poisons as antitumor drugs. , 1989, Annual review of biochemistry.

[17]  L. Szmigiero,et al.  H2O2 as a DNA fragmenting agent in the alkaline elution interstrand crosslinking and DNA-protein crosslinking assays. , 1988, Analytical biochemistry.